Sinoway Industrial Co., Ltd.

Imatinib Mesylat 220127-57-1 Imatinib Mesylat 220127-57-1

Imatinib Mesylat 220127-57-1
Verwandte Produkte
  • L-Glutathion reduziert (GSH) 70-18-8

    L-Glutathion ReducedBasic Informationen von L-Glutathion Reduced: Produktname: L-Glutathion ReducedMolecular Formel: C20H32N6O12S2Molecular Gewicht: 612.63CAS No.:70-18-8ENIECE No: 200-725-4Appearanc ...

  • Kupferpeptid (GHK) 2-CU 49557-75-7

    Kupferpeptid GHK-CuBasische Information des Kupferpeptids GHK-Cu: Produktname (GHK) 2-Cu (Kupferpeptid) SynonymeGHK-Cu (Kupferpeptid) CAS # 49557-75-7MolekularformelC28H46N12O8Cu Molekulargewicht742,2 ...

  • Isoflavone in Soja 574-12-9

    Sojabohnenextrakt1.Basisinformationen von Sojabohnenextrakt: Produktname: SojabohnenextraktQuelle: Glycin maxUsed Teil: Keim / Bohne PulpSpec .: Gesamtsoja Isoflavon 40%, 80% durch HPLCNameSoybean Extract PowderTyp ...

Grundlegende Informationen zu Imatinib Mesylat

Name

Imatinib Mesylate

Alias

GLIVEC;GLEEVEC;IMATINIB METHANESULFONATE; CGP-57148B;
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-phenyl]-benzamide Mesylate;

CAS NO.

220127-57-1

Molecular Formula

C30H35N7O4S

Molecular Weight

589.71

Quality Standard

In-house Standard

Package Size

Aluminium bag; 50g/bag; 100g/bag

Brief Introduction

Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl,
the causal agent in chronic myelogenous leukemia.
As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of
dermatological diseases. Imatinib has been reported to be an effective treatment for
FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans.

Storage condition

Preserve in tight, light-resistant containers, and store at 15℃—30℃.

Verwendung von Imatinib Mesylat

  • Ein Tyrosinkinase-Inhibitor. Sehr spezifisch für BCR-ABL, das Enzym, das mit chronischer myeloischer Leukämie (CML) und bestimmten Formen akuter lymphoblastischer Leukämie (ALL) assoziiert ist
  • Echinocandin Antimykotika, aktiv gegen Infektionen mit Aspergillus und Candida, hemmt die Zellwandsynthese
  • Antikrebs

COA von Imatinib Mesylat

TEST ITEM

SPECIFICATION

RESULTS

Appearance

White or slightly yellow crystalline powder,
homogeneous and with fine grain size.
No foreign particles are observed.

Slightly yellow crystalline Powder

Solubility

Soluble in water and in acids solutions, slightly soluble
in methanol insoluble in acetone, acetonitrile and
dilute hydroxyl alkaline solution

Confirm

Identification

Complies

Confirm

Water

≤1.0%

0.8%

Heavy metals

≤20ppm

10ppm

Melting range

212 – 220℃

214-216℃

Residue on ignition

≤0.1%

0.08%

Particle size

90% < 100 μm

50% < 50 μm

Confirm

Bulk density

NLT 0.4g/ml

0.6g/ml

Chromatographic

purity

Individual impurities: ≤0.2%

Total impurities: ≤0.5%

0.16%

0.32%

Assay

98.5%-102.0% of Imatinib mesylate,

calculated on anhydrous basis.

99.70%



Residual solvents

Ethyl acetate: ≤5000ppm

Confirm

Acetone: ≤5000ppm

Confirm

N,N-Dimethylformamide: ≤880ppm

Confirm

Methanol: ≤3000ppm

Confirm

Dichloromethane: ≤300ppm

Confirm



MORE_DETAIL Imatinib Mesylat 220127-57-1

Grundlegende Informationen zu Imatinib Mesylat

Name

Imatinib Mesylate

Alias

GLIVEC;GLEEVEC;IMATINIB METHANESULFONATE; CGP-57148B;
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-phenyl]-benzamide Mesylate;

CAS NO.

220127-57-1

Molecular Formula

C30H35N7O4S

Molecular Weight

589.71

Quality Standard

In-house Standard

Package Size

Aluminium bag; 50g/bag; 100g/bag

Brief Introduction

Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl,
the causal agent in chronic myelogenous leukemia.
As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of
dermatological diseases. Imatinib has been reported to be an effective treatment for
FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans.

Storage condition

Preserve in tight, light-resistant containers, and store at 15℃—30℃.

Verwendung von Imatinib Mesylat

  • Ein Tyrosinkinase-Inhibitor. Sehr spezifisch für BCR-ABL, das Enzym, das mit chronischer myeloischer Leukämie (CML) und bestimmten Formen akuter lymphoblastischer Leukämie (ALL) assoziiert ist
  • Echinocandin Antimykotika, aktiv gegen Infektionen mit Aspergillus und Candida, hemmt die Zellwandsynthese
  • Antikrebs

COA von Imatinib Mesylat

TEST ITEM

SPECIFICATION

RESULTS

Appearance

White or slightly yellow crystalline powder,
homogeneous and with fine grain size.
No foreign particles are observed.

Slightly yellow crystalline Powder

Solubility

Soluble in water and in acids solutions, slightly soluble
in methanol insoluble in acetone, acetonitrile and
dilute hydroxyl alkaline solution

Confirm

Identification

Complies

Confirm

Water

≤1.0%

0.8%

Heavy metals

≤20ppm

10ppm

Melting range

212 – 220℃

214-216℃

Residue on ignition

≤0.1%

0.08%

Particle size

90% < 100 μm

50% < 50 μm

Confirm

Bulk density

NLT 0.4g/ml

0.6g/ml

Chromatographic

purity

Individual impurities: ≤0.2%

Total impurities: ≤0.5%

0.16%

0.32%

Assay

98.5%-102.0% of Imatinib mesylate,

calculated on anhydrous basis.

99.70%



Residual solvents

Ethyl acetate: ≤5000ppm

Confirm

Acetone: ≤5000ppm

Confirm

N,N-Dimethylformamide: ≤880ppm

Confirm

Methanol: ≤3000ppm

Confirm

Dichloromethane: ≤300ppm

Confirm


Verwandte Artikel
Hinterlasse eine Nachricht Email uns

Wir werden uns innerhalb von 24 Stunden bei Ihnen melden.

  • TEL:+ 86-0592-5854962
  • FAX:+ 86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Etage 16, Huicheng Business Center, Nr. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//